Nuxe has been acquired by NAXICAP Partners

The shareholders of Nuxe have sold the company to NAXICAP Partners for US$66 million.

Nuxe manufactures natural cosmetics and skin and hair care products and is one of the most dynamic players in the market for natural cosmetics in pharmacies and paraphamacies. The company is headquartered in France and has 260 employees.

NAXICAP Partners is an investment firm specializing in direct and fund of fund investments. It focuses on start-ups, venture capital, growth capital, and middle-market investments, expansion capital, turnarounds, reorganization of capital ownership, funding post early-stage company creations, and buyout transactions such as leveraged buyouts, owner's buyouts, management buyouts, and management buyins. NAXICAP Partners has been a responsible and committed financial partner for companies for over 30 years, has approximately US$600 million of capital under management and is now one of the leading providers of equity financing for businesses in France.

Oaklins' team in France advised the seller in this transaction.

Service

Corporate finance services

Parties

Talk to the deal team

Thibaut de Monclin

Managing Partner

Paris, France
Oaklins France

View profile Get in touch

Hadrien Mollard

Managing Partner

Paris, France
Oaklins France

View profile Get in touch

Related deals

Kaviari has received a minority investment from idiCo

Consumer & Retail

Kaviari has received a minority investment from idiCo

Kaviari has received a minority investment from a pool of investors led by idiCo, alongside Bpifrance, IRD Invest and UI Investissement.

Learn more

AWC has acquired a significant minority stake in MyFitness

Consumer & Retail

AWC has acquired a significant minority stake in MyFitness

AWC AS, the investment company of the Norwegian family office Awilhelmsen, has acquired a 22.2% stake in MyFitness AS, the largest fitness club operator in the Baltics, becoming the MyFitness’ largest single shareholder.

Learn more

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval

Healthcare

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval

Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.

Learn more